These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24903332)

  • 1. The role of law and governance reform in the global response to non-communicable diseases.
    Magnusson RS; Patterson D
    Global Health; 2014 Jun; 10():44. PubMed ID: 24903332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal priorities for prevention of non-communicable diseases: innovations from WHO's Eastern Mediterranean region.
    Gostin LO; Abou-Taleb H; Roache SA; Alwan A
    Public Health; 2017 Mar; 144():4-12. PubMed ID: 28274382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The process of prioritization of non-communicable diseases in the global health policy arena.
    Heller O; Somerville C; Suggs LS; Lachat S; Piper J; Aya Pastrana N; Correia JC; Miranda JJ; Beran D
    Health Policy Plan; 2019 Jun; 34(5):370-383. PubMed ID: 31199439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-communicable diseases and health systems reform in low-and-middle-income countries.
    Robinson HM; Hort K
    Pac Health Dialog; 2012 Apr; 18(1):179-90. PubMed ID: 23240355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a global framework for capacity building for non-communicable disease advocacy in low- and middle-income countries.
    Shilton T; Champagne B; Blanchard C; Ibarra L; Kasesmup V
    Glob Health Promot; 2013 Dec; 20(4 Suppl):6-19. PubMed ID: 24722739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-communicable diseases in Mozambique: risk factors, burden, response and outcomes to date.
    Silva-Matos C; Beran D
    Global Health; 2012 Nov; 8():37. PubMed ID: 23171496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
    Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
    Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health concern and initiatives on the priority action towards non-communicable diseases in Tanzania.
    Mfinangai SG; Kivuyo SL; Ezekiel L; Ngadaya E; Mghamba J; Ramaiya K
    Tanzan J Health Res; 2011 Dec; 13(5 Suppl 1):365-77. PubMed ID: 26591991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tackling the global NCD crisis: innovations in law and governance.
    Thomas B; Gostin LO
    J Law Med Ethics; 2013; 41(1):16-27. PubMed ID: 23581654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global health initiatives in Africa - governance, priorities, harmonisation and alignment.
    Mwisongo A; Nabyonga-Orem J
    BMC Health Serv Res; 2016 Jul; 16 Suppl 4(Suppl 4):212. PubMed ID: 27454542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Consortium for NCD Prevention and Control in Sub-Saharan Africa (CNCD-Africa): from concept to practice.
    Amuyunzu-Nyamongo M; Owuor JO; Blanchard C
    Glob Health Promot; 2013 Dec; 20(4 Suppl):97-103. PubMed ID: 24722748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing research activity on priority interventions for non-communicable disease prevention in low- and middle-income countries: a bibliometric analysis.
    Jones AC; Geneau R
    Glob Health Action; 2012 Aug; 5():1-13. PubMed ID: 22944364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responding to non-communicable diseases in Zambia: a policy analysis.
    Mukanu MM; Zulu JM; Mweemba C; Mutale W
    Health Res Policy Syst; 2017 Apr; 15(1):34. PubMed ID: 28438177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative study of governance of evolving response to non-communicable diseases in low-and middle- income countries: current status, risks and options.
    Rani M; Nusrat S; Hawken LH
    BMC Public Health; 2012 Oct; 12():877. PubMed ID: 23067232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The legal determinants of health: harnessing the power of law for global health and sustainable development.
    Gostin LO; Monahan JT; Kaldor J; DeBartolo M; Friedman EA; Gottschalk K; Kim SC; Alwan A; Binagwaho A; Burci GL; Cabal L; DeLand K; Evans TG; Goosby E; Hossain S; Koh H; Ooms G; Roses Periago M; Uprimny R; Yamin AE
    Lancet; 2019 May; 393(10183):1857-1910. PubMed ID: 31053306
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards a comprehensive global approach to prevention and control of NCDs.
    McKee M; Haines A; Ebrahim S; Lamptey P; Barreto ML; Matheson D; Walls HL; Foliaki S; Miranda JJ; Chimeddamba O; Garcia-Marcos L; Vineis P; Pearce N
    Global Health; 2014 Oct; 10():74. PubMed ID: 25348262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating Global Priority for Addressing Rheumatic Heart Disease: A Qualitative Policy Analysis.
    Shawar YR; Shiffman J
    J Am Heart Assoc; 2020 Apr; 9(8):e014800. PubMed ID: 32308101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global health governance and the challenge of chronic, non-communicable disease.
    Magnusson RS
    J Law Med Ethics; 2010; 38(3):490-507. PubMed ID: 20880237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using concept mapping to develop a human rights based indicator framework to assess country efforts to strengthen rehabilitation provision and policy: the Rehabilitation System Diagnosis and Dialogue framework (RESYST).
    Skempes D; Melvin J; von Groote P; Stucki G; Bickenbach J
    Global Health; 2018 Oct; 14(1):96. PubMed ID: 30285888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.